4//SEC Filing
Kanesa-thasan Niranjan 4
Accession 0001209191-23-059621
CIK 0001786255other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 6:25 PM ET
Size
5.4 KB
Accession
0001209191-23-059621
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Kanesa-thasan Niranjan
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-12-20$15.46/sh−11,884$183,692→ 223,980 total
Footnotes (2)
- [F1]Reflects shares sold to cover withholding taxes upon accelerated vesting of restricted stock unit awards pursuant to a Rule10b5-1 instruction letter dated December 23, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.41 to $15.50. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Icosavax, Inc.
CIK 0001786255
Entity typeother
Related Parties
1- filerCIK 0001874021
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 6:25 PM ET
- Size
- 5.4 KB